Navigation Links
Marken Announces the Opening of a Directly Owned Clinical Trial Supply Depot in Singapore
Date:3/7/2011

LONDON, March 7, 2011 /PRNewswire/ -- As part of Marken's continued expansion of services in the APAC region, they have relocated and expanded their Singapore office to further support clients' needs for specialty logistics services. This expansion incorporates a new directly owned, purpose-built Singapore depot to support growing customer demand for Investigational Medical Product distribution.  

The new GMP compliant facility enables clients to leverage Marken's global expertise in Life Science logistics while adding key Life Science specialty services for their programs in the Asia Pacific and Middle East regions. In recent presentation to Marken employees, Gerard Barba, CEO of Marken announced, "The opening of our directly owned depot in Singapore sets the corner stone of an expanding global network of GMP compliant distribution centers for Marken."

The new 14,500 sq. ft. Clinical Trial Supply Depot offers the full range of secured storage conditions including:

  • Secured Controlled Drug (ambient)
  • 15 – 25C (controlled ambient)
  • -2 – 8C (cold storage)
  • -20C (frozen)
  • -80C (deep frozen)

Clinical Trial Logistics services offered:

  • Storage and distribution
  • Drug returns and destruction
  • Kit building
  • Biological specimen storage in ultra low freezers – short and long term

In delivering specialty logistics services to the Asia Pacific market, Marken draws upon over 30 years of experience in providing premium transportation and Life Science logistics services worldwide. The expanded Marken office in Singapore provides Life Science material logistics and Clinical Trial Supply management for Pharmaceutical and Biotech customers throughout the Asia Pacific region.  This represents Marken's latest investment in the region, which in 2010 saw the opening of a new office in Tokyo.

About Marken

Founded in 1980, Marken is focused on supporting the logistics of Life Science companies. They manage the global collection, transportation, storage and distribution of specimens and clinical trial supplies. Additionally through their depot network, Marken supports regional storage and distribution of Life Science materials. Marken's team members and network of facilities bridge the distance between patients and the essential resources of Life Science companies.

www.marken.com


'/>"/>
SOURCE Marken
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Marken Rapidly Responds to Global Supply Chain Security Measures
2. Marken Unveils New Japan Office
3. Dehaier Medical Announces Fourth Quarter and Full-Year 2010 Financial Results
4. Nephros Announces $3.2 Million Financing Through Completion of Rights Offering and Private Placement Transactions
5. ICAP Ocean Tomo Announces Four Patent Sets From Oxford Instruments - Each Represents an Important Advancement in Technology
6. Valeant Announces Pricing of Senior Notes
7. Thoratec Announces Presentations at Upcoming Investor Conferences
8. Cogdell Spencer Announces Fourth Quarter 2010 Results and Completion of Strategic Plan
9. ConvaTec Healthcare Announces Plans to Refinance Secured Term Loans
10. Pioneer® Surgical Announces New International Sales V.P.
11. Celleration Inc. Announces Award-Winning Clinical Results to Reduce Unfavorable Deep Tissue Injury Outcomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... 2016 TARE (Transarterial Radio-embolization) ... Savings and Overall Decreased Use of Hospital ... international specialist healthcare company, has today announced the ... Meeting of ISPOR (International Society for Pharmacoeconomics and ... (HCC) using yttrium-90 glass microspheres is associated with ...
(Date:5/25/2016)... FDA 510(k) clearance covers ... for urological and surgical applications Mauna ... Cellvizio®, the multidisciplinary confocal laser endomicroscopy (CLE) platform, ... US with the 12 th 510(k) clearance ... This new FDA clearance covers Confocal Miniprobes indicated ...
(Date:5/25/2016)... , Germany and GERMANTOWN, ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: ... licensing and co-development agreement with Therawis Diagnostics GmbH to develop ... be to develop and market PITX2 as a marker to ... high-risk breast cancer patients. "We are pleased to ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... 27, 2016 , ... An educational campaign aimed at everyone ... courtesy of awareness-driven celebrities and thought leaders. It also provides insight to the ... leaders such as Bioness. , As patients feel increasingly concerned about the ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... Aimed at ... human interest stories, which come courtesy of leaders in the nursing and health care ... from leading advocates and associations—namely Abilene Christian University. , As the nursing industry ...
(Date:5/26/2016)... ... May 26, 2016 , ... There are many ways to cook a ... (NHDSC) suggests that Americans prefer their dogs straight off the grill. Of the 90 ... their favorite way to cook a hot dog, far outpacing other cooking methods such ...
(Date:5/26/2016)... Atlanta, Georgia (PRWEB) , ... May 26, 2016 ... ... a certificate in intellectual property (IP) to its specialty academic programs. , Answering ... joins the college’s existing certificate programs in health law, and environmental and land ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... a significant negative impact on long-term patient survival, reports a team of UPMC ... online this week in the Journal of Thoracic and Cardiovascular Surgery, provide critical ...
Breaking Medicine News(10 mins):